CoChat

New Insights Into Androgen and Estrogen Receptor Regulation of the Male Skeleton

Open access
Khosla, Sundeep · 2015 · Journal of Bone and Mineral Research
Cited by 59

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Beginning with the report in 1994 that an adult male with homozygous loss of estrogen receptor α (ERα) had unfused epiphyses and osteopenia,1 there is now considerable evidence from observational and interventional studies (summarized in Khosla and colleagues2) that estrogen is the dominant regulator of bone metabolism in men. Indeed, a legitimate argument can be made that testosterone is largely a prohormone for the skeleton, with its effects on bone mediated principally via aromatization to estrogen, although it remains likely that testosterone contributes to bone size via effects on periosteal apposition and perhaps indirectly to bone mass by increasing muscle mass. A series of human investigations from our group have certainly contributed to building this argument. Perhaps the most convincing of these was a direct interventional study published almost 15 years ago,3 which is summarized briefly here, because it is instructive to revisit the data from that human study in light of the article in this issue of JBMR by Ucer and colleagues4 on the contributions of skeletal androgen receptor (AR) versus ERα signaling toward regulating bone metabolism in mice. Thus, the key questions are: 1) Are the findings from the mouse study translatable to humans? 2) Can the new mouse data help us better understand previous findings in humans? In our human study, we used an experimental design in which sex steroid production was suppressed in adult men using a GnRH agonist followed by selective replacement of either estrogen or testosterone, or both.3 An aromatase blocker was administered to all subjects in order to examine effects of testosterone on bone in the absence of conversion to estrogen. For the purposes of this discussion, the bone resorption marker, N-telopeptide of type I collagen (NTx) will be used to reflect sex steroid effects on bone turnover; independent effects of estrogen and testosterone on bone formation markers were also observed, but these were largely concordant with the findings for NTx, so to simplify the discussion, NTx is used here to reflect bone remodeling changes in this study. As shown in Fig. 1A, compared with the sex steroid replete state (+T, +E), complete sex steroid deficiency (–T, –E) resulted in an increase in NTx of ∼35% over 3 weeks. Estrogen replacement alone, in the absence of testosterone (–T, +E), was able to almost completely prevent this increase in bone resorption, which increased only by ∼10%; by contrast, testosterone replacement alone (+T, –E) was largely ineffective, with NTx increasing in this group by ∼25%. Using a rigorous 2-factor ANOVA model and these percentages, we concluded that even in men, estrogen exerted the dominant effect on bone resorption, with testosterone making a much smaller contribution. Based on the relative magnitude of the changes, our best estimate was that of the total effect of sex steroids on bone resorption in men, estrogen accounted for ∼70% and testosterone for at most ∼30% of the effect.3 The findings of this interventional study were largely confirmed by a similar study by Leder and colleagues5 using bone turnover markers and a more recent study by Yu and colleagues6 demonstrating that even in the setting of testosterone sufficiency, induced estrogen deficiency led to significant bone loss in men. In addition, several studies found that selective estrogen receptor modulators exerted a protective effect on bone in men with low endogenous estrogen levels,7-9 whereas treatment with an aromatase inhibitor10 or with the nonaromatizable androgen, dihydrotestosterone, resulted in bone loss.11 Finally, a large body of observational data (summarized in Khosla and colleagues2) have shown that in men, serum estrogen levels were better predictors than serum testosterone levels of bone mineral density, rates of bone loss, and fracture risk. Thus, the collective evidence from both interventional and observational human studies is now overwhelming that estrogen plays a much more significant role in regulating bone metabolism in men than testosterone. To better understand the human data at a mechanistic level, Ucer and colleagues4 from the Manolagas group report in the current issue of JBMR on the use of a genetic approach to evaluate the role of AR versus ER signaling in bone cells on bone metabolism in mice. Although some data on female mice were also included in the article, this discussion will be limited to the male mice in order to compare the findings to our human male study. Thus, Ucer and colleagues4 generated mice with targeted deletion of the AR or ERα either in osteoblast lineage (ARf/y;Prx1-Cre or ERαf/f;Osx1-Cre) or myeloid lineage cells (and hence osteoclasts) (ARf/y;LysM-Cre or ERαf/f;LysM-Cre). Although ERβ deletion was not included in any of these models, the available evidence from previous mouse models is that ERβ may play a role in the female, but not male, skeleton,12, 13 so the authors accordingly focused on the AR and ERα. One of t

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.2529

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Khosla, S.
Venue
Journal of Bone and Mineral Research
Published
2015-04-09
Volume
30
Issue
7
Pages
1134-1137
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W1766472862
Cited by
59
References
6
FWCI
5.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.